文献速递关节外科运动医学

体重指数对股骨髋臼撞击综合征髋关节镜术后10年结局的影响:匹配分析

The Effect of Body Mass Index on Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome: A Matched Analysis With 10-Year Follow-up.
PubMed 文献 · Am J Sports Med · 2026-01-21

该队列研究纳入2012年1月至2014年6月期间因股骨髋臼撞击综合征(FAIS)接受髋关节镜手术的患者168例,按体重指数(BMI)分为正常体重组、超重组和肥胖组,每组56例,按年龄和性别1:1:1匹配,平均随访10.3±0.4年。结果显示所有BMI组患者报告结局评分均显著改善,但肥胖和超重患者10年无全髋关节置换术(THA)生存率显著低于正常体重患者(80.4% vs 85.7% vs 96.4%,P=0.026)。

要点

  • 所有BMI组FAIS患者髋关节镜术后10年患者报告结局评分均显著改善(P<0.001)。
  • 肥胖和超重患者10年无THA生存率显著低于正常体重患者(80.4% vs 85.7% vs 96.4%,P=0.026)。
  • 所有BMI组达到最小临床重要差异(MCID)和患者可接受症状状态(PASS)的比率相似。

核心结论

  • 所有BMI组FAIS患者髋关节镜术后10年所有结局评分均显著改善。
  • 肥胖患者大多数随访时间点患者报告结局评分倾向更差,但较术前改善幅度相似。
  • 肥胖和超重患者转为THA的比率显著高于正常体重患者。

研究设计与样本

  • 队列研究,证据等级3。
  • 纳入2012年1月至2014年6月期间接受手术的患者,收集术前、2年、5年和10年患者报告结局评分。
  • 患者按BMI分为正常体重组(18.5-24.9 kg/m2)、超重组(25.0-29.9 kg/m2)和肥胖组(≥30.0 kg/m2),按年龄和性别1:1:1匹配。
  • 共纳入168例患者,平均随访10.3±0.4年,每组56例。

主要发现

  • 所有组患者报告结局评分至10年随访均显著改善(所有P<0.001)。
  • 多变量分析显示HOS-ADL评分在术前(P<0.001)、2年(P=0.008)、5年(P=0.005)和10年(P=0.023)存在显著差异。
  • mHHS评分在2年(P=0.006)、5年(P=0.041)和10年(P=0.027)随访时组间存在差异。
  • 所有患者无论BMI如何,所有患者报告结局评分的MCID和PASS达成率相似。
  • 肥胖和超重患者无THA生存率显著低于正常体重患者(80.4% vs 85.7% vs 96.4%,P=0.026)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term outcomes after hip arthroscopy for femoroacetabular impingement syndrome (FAIS) have been promising, but no studies to date have examined the effect of body mass index (BMI) on 10-year outcome scores and reoperation rates. PURPOSE: To compare outcome scores and reoperation rates between normal-weight, overweight, and obese patients undergoing hip arthroscopy for FAIS at 10-year follow-up. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Preoperative, 2-year, 5-year, and 10-year scores for patient-reported outcome measures (PROMs) in patients undergoing surgery between January 2012 and June 2014 were collected. These included the Hip Outcome Score-Activities of Daily Living (HOS-ADL), Hip Outcome Score-Sports Subscale (HOS-SS), modified Harris Hip Score (mHHS), 12-item International Hip Outcome Tool (iHOT-12), visual analog scale (VAS) for pain, and VAS for satisfaction. Clinically significant outcomes were also collected including the minimal clinically important difference (MCID) and patient acceptable symptom state (PASS). Patients were stratified into the normal-weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), or obese (≥30.0 kg/m2) group and matched in a 1:1:1 ratio, controlling for age and sex. Reoperation-free survivorship was determined. RESULTS: A total of 168 patients, with a mean follow-up time of 10.3 ± 0.4 years, who underwent hip arthroscopy for FAIS were included in the study: 56 normal weight, 56 overweight, and 56 obese. While all groups had similar significant improvements in PROM scores by 10-year follow-up (all P < .001), multivariable analysis revealed significant differences in HOS-ADL scores preoperatively (P < .001) and at 2 years (P = .008), 5 years (P = .005), and 10 years (P = .023). The groups differed in mHHS scores at 2-year (P = .006), 5-year (P = .041), and 10-year follow-up (P = .027). All patients, regardless of BMI, had similar achievement rates of the MCID and PASS for all PROMs. Obese and overweight patients had significantly worse rates of total hip arthroplasty (THA)-free survivorship compared with normal-weight patients (80.4% vs 85.7% vs 96.4%, respectively; P = .026). CONCLUSION: There were significant improvements in all outcome scores across all BMI groups by 10 years after the arthroscopic treatment of FAIS. Obese patients tended to have worse PROM scores at most follow-up time points but similar magnitudes of improvement from preoperatively. Obese and overweight patients converted to THA at significantly higher rates compared with normal-weight patients.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Moran TE, Hu EY, Cervantes JE, et al. The Effect of Body Mass Index on Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome: A Matched Analysis With 10-Year Follow-up. Am J Sports Med. 2026. PMID: 41562525. doi:10.1177/03635465251400355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。